Equities

Haemonetics Corp

Haemonetics Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)85.55
  • Today's Change0.12 / 0.14%
  • Shares traded266.92k
  • 1 Year change+4.35%
  • Beta0.3589
Data delayed at least 15 minutes, as of Nov 22 2024 20:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 30 2024202420232022
OPERATIONS
Net income11811543
Depreciation/depletion979398
Non-Cash items533441
Cash taxes paid, supplemental531824
Cash interest paid, supplemental21146.19
Changes in working capital(75)26(15)
Total cash from operations182273172
INVESTING
Capital expenditures(66)(110)(97)
Other investing and cash flow items, total(256)(34)10
Total cash from investing(322)(144)(86)
FINANCING
Financing cash flow items(6.81)(23)(4.8)
Total cash dividends paid------
Issuance (retirement) of stock, net7.21(68)6.55
Issuance (retirement) of debt, net38(9.63)(18)
Total cash from financing38(100)(16)
NET CHANGE IN CASH
Foreign exchange effects(3.19)(3.94)(2.98)
Net change in cash(106)2567
Net cash-begin balance/reserved for future use284259192
Net cash-end balance/reserved for future use179284259
SUPPLEMENTAL INCOME
Depreciation, supplemental979398
Cash interest paid, supplemental21146.19
Cash taxes paid, supplemental531824
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.